Prevacare R
Drug - Prevacare R
The trade name of the product as shown on the labeling.
Dosage -
SOLUTION; TOPICAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Chlorhexidine Gluconate
Multiple ingredients are in alphabetical order.
Strength -
0.5%
The potency of the active ingredient(s), Chlorhexidine Gluconate. May repeat for multiple part products.
Applicant -
J AND J
The firm name holding legal responsibility for Prevacare R. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
072292
The FDA assigned number to Prevacare R. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Prevacare R. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Jan 28, 1992
The date Prevacare R was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of Prevacare R. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
OTC
The group or category of approved drugs Prevacare R is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Johnson And Johnson Medical Inc
The full name of the firm holding legal responsibility for the new application of Prevacare R.
Prevacare R
|
